Cargando…

Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes

AIM: Noninvasive assessment of infraclinic coronary atherosclerosis by coronary artery calcium score (CAC) measurement leads to the identification of incidental findings. The aim of this study was to determine the prevalence of incidental findings following systematic CAC assessment in diabetic pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaudillière, Mélanie, Marsot, Charlotte, Balaire, Laetitia, Groisne, Laure, Moret, Myriam, Villar-Fimbel, Sylvie, Douek, Philippe, Moulin, Philippe, Charrière, Sybil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143389/
https://www.ncbi.nlm.nih.gov/pubmed/34029335
http://dx.doi.org/10.1371/journal.pone.0251693
_version_ 1783696742620856320
author Gaudillière, Mélanie
Marsot, Charlotte
Balaire, Laetitia
Groisne, Laure
Moret, Myriam
Villar-Fimbel, Sylvie
Douek, Philippe
Moulin, Philippe
Charrière, Sybil
author_facet Gaudillière, Mélanie
Marsot, Charlotte
Balaire, Laetitia
Groisne, Laure
Moret, Myriam
Villar-Fimbel, Sylvie
Douek, Philippe
Moulin, Philippe
Charrière, Sybil
author_sort Gaudillière, Mélanie
collection PubMed
description AIM: Noninvasive assessment of infraclinic coronary atherosclerosis by coronary artery calcium score (CAC) measurement leads to the identification of incidental findings. The aim of this study was to determine the prevalence of incidental findings following systematic CAC assessment in diabetic patients with high cardiovascular risk, to identify the determinants, and to assess the midterm consequences of these findings in patient care. METHODS: 732 consecutive asymptomatic patients (187 type 1 diabetes (TD1), 482 type 2 diabetes (TD2) and 63 type 3 diabetes (TD3)) aged 60.6±0.7 years who had a CAC assessment by Multiple Detector Computed Tomography between 2015 and 2017 were systematically included. Clinical and biological data were collected from medical electronic files. RESULTS: 117/732 diabetic patients (16.0%) had incidental findings of which 105 (14.3%) were unknown. Incidental findings were more frequent in TD3 (23.8%) and TD2 (17.0%) than in TD1 (10.7%) (p = 0.05). 76 diabetic patients (10.4%) had lung abnormalities, mainly pulmonary nodules (31 patients, 4.2%). The other incidental finding were pericardial (1.5%), vascular (1.2%), thymic (0.7%) and digestive diseases (0.5%). 42.6% of patients with incidental findings had an additional TDM and 56.8% a specialized medical advice. In 10 patients (9.3% of incidental findings), the identification of incidental finding led to a specific treatment of the underlying disease. In multivariate analysis, microalbuminuria, type of diabetes (TD2/TD3 vs TD1) and smoking were significantly associated with incidental findings (p = 0.003; p = 0.026; p = 0.050 respectively). CONCLUSIONS: Incidental findings are not rare in diabetic patients upon CAC assessment. A fraction of them are accessible to specific treatment. These findings raise the question if a systematic low dose chest TDM should be conducted in TD2 or TD3 patients and in any diabetic smokers by enlarging the window used for CAC assessment.
format Online
Article
Text
id pubmed-8143389
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-81433892021-06-07 Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes Gaudillière, Mélanie Marsot, Charlotte Balaire, Laetitia Groisne, Laure Moret, Myriam Villar-Fimbel, Sylvie Douek, Philippe Moulin, Philippe Charrière, Sybil PLoS One Research Article AIM: Noninvasive assessment of infraclinic coronary atherosclerosis by coronary artery calcium score (CAC) measurement leads to the identification of incidental findings. The aim of this study was to determine the prevalence of incidental findings following systematic CAC assessment in diabetic patients with high cardiovascular risk, to identify the determinants, and to assess the midterm consequences of these findings in patient care. METHODS: 732 consecutive asymptomatic patients (187 type 1 diabetes (TD1), 482 type 2 diabetes (TD2) and 63 type 3 diabetes (TD3)) aged 60.6±0.7 years who had a CAC assessment by Multiple Detector Computed Tomography between 2015 and 2017 were systematically included. Clinical and biological data were collected from medical electronic files. RESULTS: 117/732 diabetic patients (16.0%) had incidental findings of which 105 (14.3%) were unknown. Incidental findings were more frequent in TD3 (23.8%) and TD2 (17.0%) than in TD1 (10.7%) (p = 0.05). 76 diabetic patients (10.4%) had lung abnormalities, mainly pulmonary nodules (31 patients, 4.2%). The other incidental finding were pericardial (1.5%), vascular (1.2%), thymic (0.7%) and digestive diseases (0.5%). 42.6% of patients with incidental findings had an additional TDM and 56.8% a specialized medical advice. In 10 patients (9.3% of incidental findings), the identification of incidental finding led to a specific treatment of the underlying disease. In multivariate analysis, microalbuminuria, type of diabetes (TD2/TD3 vs TD1) and smoking were significantly associated with incidental findings (p = 0.003; p = 0.026; p = 0.050 respectively). CONCLUSIONS: Incidental findings are not rare in diabetic patients upon CAC assessment. A fraction of them are accessible to specific treatment. These findings raise the question if a systematic low dose chest TDM should be conducted in TD2 or TD3 patients and in any diabetic smokers by enlarging the window used for CAC assessment. Public Library of Science 2021-05-24 /pmc/articles/PMC8143389/ /pubmed/34029335 http://dx.doi.org/10.1371/journal.pone.0251693 Text en © 2021 Gaudillière et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Gaudillière, Mélanie
Marsot, Charlotte
Balaire, Laetitia
Groisne, Laure
Moret, Myriam
Villar-Fimbel, Sylvie
Douek, Philippe
Moulin, Philippe
Charrière, Sybil
Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes
title Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes
title_full Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes
title_fullStr Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes
title_full_unstemmed Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes
title_short Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes
title_sort higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143389/
https://www.ncbi.nlm.nih.gov/pubmed/34029335
http://dx.doi.org/10.1371/journal.pone.0251693
work_keys_str_mv AT gaudillieremelanie higherprevalenceofincidentalfindingsidentifieduponcoronarycalciumscoreassessmentintype2andtype3diabetesversustype1diabetes
AT marsotcharlotte higherprevalenceofincidentalfindingsidentifieduponcoronarycalciumscoreassessmentintype2andtype3diabetesversustype1diabetes
AT balairelaetitia higherprevalenceofincidentalfindingsidentifieduponcoronarycalciumscoreassessmentintype2andtype3diabetesversustype1diabetes
AT groisnelaure higherprevalenceofincidentalfindingsidentifieduponcoronarycalciumscoreassessmentintype2andtype3diabetesversustype1diabetes
AT moretmyriam higherprevalenceofincidentalfindingsidentifieduponcoronarycalciumscoreassessmentintype2andtype3diabetesversustype1diabetes
AT villarfimbelsylvie higherprevalenceofincidentalfindingsidentifieduponcoronarycalciumscoreassessmentintype2andtype3diabetesversustype1diabetes
AT douekphilippe higherprevalenceofincidentalfindingsidentifieduponcoronarycalciumscoreassessmentintype2andtype3diabetesversustype1diabetes
AT moulinphilippe higherprevalenceofincidentalfindingsidentifieduponcoronarycalciumscoreassessmentintype2andtype3diabetesversustype1diabetes
AT charrieresybil higherprevalenceofincidentalfindingsidentifieduponcoronarycalciumscoreassessmentintype2andtype3diabetesversustype1diabetes